Ads
related to: breast cancer drug- Overall Survival Results
See Updated Overall Survival Data
For This Treatment Option
- Dosing & Administration
Read More About Dosing
And How To Prescribe
- Patient Support
View The The Service Request Form
To Gain Access To Support Programs
- Financial Resources
Learn About The Available Access
Programs For Your Patients
- Official Video Library
See A Medical Expert Discuss
Overall Survival Data For mBC
- Safety Profile
View The Full Safety Profile And
See Side Effects For This Option
- Overall Survival Results
Search results
This drugstore anti-aging moisturizer is just as good as my favourite $515 face cream
Yahoo Canada Style· 21 hours agoInitially, it smelled pleasant, but said, "As the day passes, I can still smell it, and it smells...
Integration of pharmacies with physician practices has little impact on cancer drug expenditures,...
Medical Xpress· 6 days agoIn addition, there were no discernible benefits for patients as measured by out-of-pocket expenditures, medication adherence, and the amount of time before treatment of cancer
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks via Yahoo Finance· 6 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent...
... for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer...
FOX 4 Kansas City· 7 days agoThe data, which mark the first promising clinical results for a CDK2 inhibitor in combination with an approved CDK4/6 inhibitor, will be presented at the 2024 American Society of Clinical Oncology ...
Gilead and Cartography enter deal to develop cancer therapies
Pharmaceutical Technology via Yahoo Finance· 1 day agoCartography looks forward to working with Gilead and leveraging the team’s expertise in oncology and...
What to know about the blood test to detect colon cancer recommended by an FDA panel
ABC News· 6 days agoA blood test to screen for colorectal cancer is one step closer to receiving approval from the U.S....
BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study
Digital Journal· 2 days ago“We are extremely excited about partnering with BeiGene on this novel immunotherapy approach with planned expansion to prostate...immunotherapy has shown survival and clinical benefit in patients ...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 7 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
AstraZeneca shares target raised by Argus on new drug approvals By Investing.com
Investing.com· 3 hours agoOn Thursday, AstraZeneca PLC (NASDAQ:LON:AZN) shares received an updated price target from a market...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 3 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
Ads
related to: breast cancer drug